|
| |
Overview
Financial Highlight
Headlines
Business Background Genetec Technology Bhd is principally engaged in investment holding, designing and building of customized factory automation equipment and integrated vision inspection systems. The company operates solely in the Industrial Automation segment. The company serves a diverse set of markets including automotive, hard disk drive industries, semiconductor, and electronics. Its primary geographic markets are Thailand, the United States of America, the United Kingdom, Malaysia, China, and others. Geographically, Malaysia and China contribute the vast majority of total revenue.
  tracylim Yup, I still maintain my medium term target at 2.50. As you can see GENETEC is going through transformation from a counter that was heavily manipulated before it's 10 to 1 consolidation process and move all the way to become a more diversified profit making company, with reasonable dividends and organic growth. Of course I can't deny there are still sharks swimming in the pool, which is very obvious to everyone. Yet, with the current result, which is amongst its best performance if you would go through all it's previous quarters, the lower they push, the better price we will get. That's why I hope the market makers can push down some more so that I can sweep the shares over. What I guess is they would most probably maintain the price at 1.7-1.8, do the collection and later push up. And my 2.50 (or even 3.00) target will be realistic, particularly if GENETEC can give us better results or at least maintain its performance for another one or two quarters. 12/03/2019 9:22 PM Investor 9999 Agred with Tracy Lim. below is what I posted on my analysis in my investment group 28/03/2019 8:43 AM Investor 9999 GENETEC – Target price 256 to 284 based on estimated FY 2019 EPS of 28.45 Sen (YTD FY 2019 EPS 23.26 Sen) using PE range 9 to 10. Fantastic corporate profit record for Q3 with a net profit of RM4.991 mil (with EPS 12.42 Sen) attributable to shareholders and 9 mths YTD net profit of RM 9.346 mil (with EPS 23.26 Sen) A dividend of 2.5 Sen was declared making YTD interim dividend in total of 5 Sen, Target price 256 to 284 based on estimated FY 2019 EPS of 28.45 Sen (YTD FY 2019 EPS 23.26 Sen) using PE range 9 to 10. I am expecting Q4 to be moderate as the Directors of the Group anticipate that the Group will achieve satisfactory performance for the remaining quarter. The Company has announced yesterday it has secured contracts of RM46.1 mil comprising RM32.5 for automotive and RM 13.5 for Semicon, electronic and HDD for FY 2020 , see attached announcement. Market talk is another contract of RM40 mil could be finalised in due course. I have stated in my earlier posting You cannot judge Genetic performance Q on Q as its business model involved design (for acceptance by customers), construction and installation of industrial system and equipment for its clients in HDD and Automotive industries which take 6 to 12 mths from design to completion and billing. 28/03/2019 8:43 AM Investor 9999 Review of 9 mths YTD FY 2019 vs 9 mths YTD FY 2018 (9 months period ended 30 Sept) For the YTD 31 Dec FY 2019, the Group recorded a revenue of RM82.8 mil compared to RM72.0 mil for YTD FY 2018, which is an increase of 15%. Gross profit margin has increased to 21.3% compared to 18.4% for 2018. The Group recorded a net tax (PAT after Non-controlling interest) of RM9.426 mil for the YTD FY 2019 as compared to RM3.702 mil in the corresponding 9 mths for period ended 31 Dec 2018, an increase of 255. The increase in profit was mainly attributable to improved operational efficiency. Refer to Excel Table Attached. REVIEW OF PERFORMANCE Q3 For the current quarter ended 31 December 2018, the Group recorded a revenue of RM34.5 million, an increase of 25.5% or RM7.0 million as compared to a revenue of RM27.5 million recorded in the preceding corresponding quarter ended 31 December 2017. The Group recorded a net profit before tax of RM5.1 million for the current quarter under review as compared to a net profit before tax of RM3.7 million in the preceding corresponding quarter ended 31 December 2017.The increase in net profit before tax was mainly due to higher sales volume achieved and improved operational efficiency. Genetec has a strong balance sheet with a nil net gearing. Its current assets is RM73.7 mil compared to current liabilities of RM 26.1mil. Its Share Capital is RM62.2 mil making up of 40.2 mil shares with a net asset of 191 Sen per share. 28/03/2019 8:45 AM Investor 9999 Just buy and keep wait for it to explode like Dufu when time is right. 28/03/2019 8:45 AM  SuperPanda lowest was at 1.14, so i buy some at 1.17.. this cmpny should give bonus share or split so price can be cheaper can do for 1:1 bonus 29/07/2019 1:07 PM Hew Kiong Peng George cold eye got 20000 lots in genetec n that ronnie tan also got nearly 10000 lots 30/07/2019 7:11 AM abc123 People already forgotten one so called sifu recommended this many years ago. Fried high then crashed! So many still licking the wounds. So make sure you are not the last man( or woman) standing if it happens again! 30/07/2019 9:07 AM peng01 https://www.theedgemarkets.com/article/genetec-gets-new-orders-worth-rm385m-january 04/02/2020 4:17 PM Investor 9999 Genetec expect price gap up for a fantastic Q3 result with Q3 EPS 20 Sen and 9 mth YTD EPS of 18.1 Sen Valuation of RM2 to RM2.50 with PE range of 8 to 10. Genetec is due for rerating given its improvement in top and bottom line in Q3 and also its recent announcement on 4 Feb 2020 on securing new orders of RM38.5 mil for its new financial year ended 31 March 2021. At 163 Sen, it is currently trading on historical PE 11.8 based on FY 2019 EPS of 13.82 Sen and forward PE 6.52 using a projected EPS 25 Sen for FY2020. Based on our projected FY 2020 EPS of 25 Sen ( 9 mth YTD EPS is 18.1 Sen) , using PE 8 to 12 would give GENETEC a valuation range of RM2.00 to RM2.50. For 9 mth YTD FY 2020 the Co recorded a revenue of RM72 mil (9 mth YTD FY 2019 RM82.8 mil) and a net profit of RM7.3 mil (9 mth YTD FY 2019 RM9.7 mil) with an EPS of 18.1 Sen (FY 2019 23.45 Sen). Note that in FY 2019, there was an impairment of RM5 mil goodwill written off in Q4 FY 2019 turning it into a net loss after tax of RM 3.7 mil for Q4 and FY 2019 result with a lower profit of RM6 mil with EPS 13.82 Sen REVIEW OF PERFORMANCE For the current quarter Q3 ended 31 December 2019, the Group recorded a revenue of RM40.1 million, an increase of 16.2% or RM5.6 million as compared to a revenue of RM34.5 million recorded in the preceding corresponding quarter ended 31 December 2018. The Group recorded a net profit before tax of RM8.1 million (NPAT RM8.1 mil with EPS of 20 Sen) for the current quarter under review as compared to a net profit before tax of RM5.0 million (NPAT RM5.0 mil with EPS of 12.4 Sen) in the preceding corresponding quarter ended 31 December 2018.The increase in net profit before tax was mainly attributable to higher sales volume achieved and improved operational efficiency. 27/02/2020 7:03 AM cola Don't worry about CKV resignation. His shareholding has increased from 10.19% (June 2019) to 15.59% as of yesterday. 24/06/2020 10:48 AM cola He is the biggest shareholder and a non executive director, not the key persons that run day to day operation. All the top 3 shareholders (and they are in the BOD) are increasing their shareholding in the company in the last 6 months. They wont do that unless they have confidence in the business. 24/06/2020 9:55 PM Gen2 cola go check back how many shares the top management especially CKV owned 10+ years before compare now. You know what I mean by worry. 24/06/2020 11:57 PM cola Talking about history about this stock. It was once a darling stock back in 2015/2016. During the peak time, the top shareholder reduced his holding quite significantly before the price crash. After that, there was a reverse split (10:1). Now, all the top 3 shareholders are increasing their shareholding again. However, the main reason I am in is because I think they are in the right business; not entirely due the insider activities. I see it as potential turn-around stock. I have not looked at the QR in detailed, but the business was impacted due to COVID19, right? and also some impairment loss.... Anyway, there are still a lot uncertainties in the market. Consider selling or reducing position if you are worried. 25/06/2020 9:32 AM Xcalibre Warrior Traders VIP owner... how much you still hold in Genetec since buy call was made earlier?Gold club pulak.... 25/06/2020 9:56 AM Xcalibre Warrior Traders VIP owner... are you buying more now since lower price? You need to walk the talk.... and reply here .... 25/06/2020 9:58 AM Xcalibre Don't think the Warrior Traders VIP owner has the balls to answer queries here.... so called stock guru.... 25/06/2020 10:06 AM Gen2 cola they have been in the right business many years ago, with CKV leadership the results were mixed but still generating not too bad profits. Going forward, without CKV can they still performed the mixed results as previous or they are able to outperform in the semicon related market ? 25/06/2020 11:16 AM  zhangliang Supporting well, will fulfill order soon since mco lifted. Next qr sure rebound kao kao 26/06/2020 11:30 PM Dkk08 Xcaliber,You still dare to trust those gurus recommendation?? WTVIP on 23/6 posted"Genetec director keep on buying what u afraid of"? But on 24/6 posted "what we learn from Genetec results,as a trader we need to adhere to cut loss point 1.49" U-tun like politicians la..hahaha 26/06/2020 11:58 PM zhangliang Slow & low volume. When will volume come in. Dufu almost rm6, JCY & Notion oso Jalan. Don keep me waiting long time 11/07/2020 9:29 PM Xcalibre @Dkk08 Not trusting the So called Stock Guru (Warrior Traders VIP pulak)... all these con men strategy and pump and dump......Luckily I didn't pay for their course... 17/07/2020 4:54 PM Xcalibre This is con artist job... Up already quick Chao first before the so called Warrior Trader get out before you... Don't be conned by WT in tricking you to enter.. Once you enter.. WT will sell 10/08/2020 2:26 PM  | |
